# Pharmacokinetics of Tipranavir Soft Elastic Capsules (SEDDS) and Ritonavir and Their Effects on Cytochrome P-450 (3A4) in Healthy Volunteers

> **NCT02251132** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 113 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** TPV low 1
- **DRUG:** TPV low 2
- **DRUG:** TPV medium
- **DRUG:** TPV high 1
- **DRUG:** TPV high 2
- **DRUG:** RTV low
- **DRUG:** Ritonavir high
- **DRUG:** Radiolabelled erythromycin

## Key facts

- **NCT ID:** NCT02251132
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** 2000-12
- **Final completion:** —
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2014-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02251132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02251132, "Pharmacokinetics of Tipranavir Soft Elastic Capsules (SEDDS) and Ritonavir and Their Effects on Cytochrome P-450 (3A4) in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02251132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*